Ved efterfølgende 2, 0 mikrogram/ kg/ minut kontinuerlig infusion giver dette regimen en > 80% hæmning af ADP- induceret ex vivo trombocytaggregation, ved fysiologiske calciumkoncentrationer, hos mere end 80% af patienterne.
When followed by a 2.0 microgram/ kg/ min continuous infusion, this regimen produces a > 80% inhibition of ADP-induced ex vivo platelet aggregation, at physiologic calcium concentrations, in more than 80% of patients.